Clinical and biological implications of driver mutations in myelodysplastic syndromesElli Papaemmanuil, Peter J. Campbell, David C. Wedge et al.|Blood|2013Cited by 1.8k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring SideroblastsElli Papaemmanuil, Peter J. Campbell, Mario Cazzola et al.|New England Journal of Medicine|2011Cited by 1.2k
Erythroid response to treatment with G‐CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive modelEva Hellström‐Lindberg, Peter L. Greenberg, Robert S. Negrin et al.|British Journal of Haematology|1997Cited by 314
Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associationsAndrea Pellagatti, Jacqueline Boultwood, Richard N. Armstrong et al.|Blood|2018Cited by 248